ArticleJournal of oncology2019

HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia.

Aida Vitkevičienė et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.